Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-30 @ 5:18 AM
Study NCT ID:
NCT04742959
Status:
COMPLETED
Last Update Posted:
2024-04-26
First Post:
2021-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Sponsor:
TransThera Sciences (Nanjing), Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
| None | Cholangiocarcinoma | View |
| None | HER2-negative Breast Cancer | View |
| None | Triple Negative Breast Cancer | View |
| None | Bladder Cancer | View |
| None | Small-cell Lung Cancer | View |
| None | Prostate Cancer | View |
| None | Thyroid Cancer | View |
| None | Sarcoma | View |
| None | Gastric Cancer | View |
| None | Gallbladder Cancer | View |
Keywords: